My general interests are in GI and GU malignancies. Specifically, I have focused on prostate and pancreatic cancers. In prostate cancer, I have been looking at alternative hormonal therapies, and also developing chemotherapy for hormone refractory disease. We have successfully conducted a trial showing the utility of Mitoxantrone and Taxotere in treating this cancer. In addition, we have looked at multiple other newer compounds, including monoclonal antibodies, viral and other biological therapies. For pancreatic malignancies, we have helped to establish the activity of Gemcitabine in this cancer, and are looking at ways to increase its activity by coming up with a unique combination of Gemcitabine and radiation therapy. We are also running one of the few clinical trials in the country for gallbladder and cholangiocarcinomas, and have thereby become a national referral center for these cancers. Finally, with our colleagues in radation oncology, we have established the utility of combined radiation therapy and chemotherapy in downstaging rectal cancers safely and effectively.
| 1975-1979 | University of Illinois, Urbana, IL
BA Honors Biology, Summa Cum Laude BS Electrical Engineering, Highest Honors Selected Honors: Phi Beta Kappa, Tau Beta Pi, Bronze Tablet Scholar |
| 1979-1984 | Harvard Medical School, Boston, MA
MD, Magna Cum Laude Participant in Harvard-MIT program in Health Sciences and Technology Thesis: The Immune System of a Naturally Occurring Hematopoietic Chimeric Primate: Saguinus oedipus |
| 1984-1985 | Medicine Internship, Duke University Medical Center, Durham, NC |
| 1985-1987 | Resident in Internal Medicine, Duke University Medical Center, Durham, NC |
| 1987-1991 | Fellow in Hematology-Oncology, Cancer Research Institute, University of California, San Francisco, CA |
| 1982-1983 | Karin Grunebaum Cancer Research Foundation Fellow |
| 1989-1991 | American Cancer Society Physician Training Award |
| 1991-1999 | Assistant Professor, Department of Medicine, Division of Hematology-Oncology, Washington University , St. Louis, MO |
| 1991-1994 | Director, Washington University Hematology Laboratory |
| 1999-present | Associate Professor, Department of Medicine, Division of Oncology, Washington University, St. Louis, MO |
| 1991-present | Barnes Hospital Cancer Committee (Co-chair Data Services Subcommittee) |
| 1992-1998 | Therapeutic Nutrition Committee of Barnes Hospital |
| 1994-present | Prostate Committee, Cadre Member, CALGB |
| 1994-present | Co-chair, GI Committee, Hoosier Oncology Group |
| 1996-present | Protocol Review and Monitoring Committee, Washington University Cancer Center (Co-chair since 2002) |
| 1997-1998 | GI Committee, Cadre Member, CALGB |
| 2006-present | Director, Hematology-Oncology Fellowship Program, Washington University |
| American Association for the Advancement of Science | |
| American Association for Cancer Research | |
| American College of Physicians | |
| American Federation for Clinical Research | |
| American Medical Association | |
| American Society of Hematology | |
| American Society of Internal Medicine | |
| American Society of Clinical Oncology | |
| American Urological Association | |
| Cancer and Leukemia Group B
Cadre Member - Prostate Committee Cadre Member - GI Committee |
|
| Hoosier Oncology Group
Co-Chair - GI Committee |
| 1987 | Diplomate of American Board of Internal Medicine |
| 1989 | Board Certified in Oncology |
| 1990 | Board Certified in Hematology |